Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.
The Seattle startup is looking to partner with pharmaceutical companies and offer its yeast fusion sequencing technology as a contracted research service.
The team saw risky mutations in colorectal cancer, polyp, and Lynch syndrome-related genes in almost 4 percent of CRC patients diagnosed at 72 years old, on average.
Discover's The Crux blog writes that the expression of some genes ramp up after an organism dies.
The software, presented at the ISMB/ECCB conference, helps researchers fill in gaps in the human epigenome thanks to 3D deep-learning techniques.
The longtime quest of one Microsoft data scientist to stop infant crib deaths has grown into a genomics and AI research program with lofty goals.
In Nature this week: a genome-wide association study of peripheral artery disease among US veterans, and more.
The researchers found that background TP53 gene mutations increase with age and could affect efforts to develop liquid biopsy-based cancer screening tests.
In PLOS this week: novel loci linked to QRS duration in Hispanic/Latino populations, group B Streptococcus in Southeast Asia, and more.
The virology department at UW will offer a number of support services to diagnostics developers, including particular expertise in digital PCR and sequencing technologies.
In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.
Canadian regulators are beginning to share information from new drug studies, Undark reports.
In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.